Personalized Analysis and Treatment of Heart Disease
Cleerly (cleerlyhealth.com) earns a Brand Analyzer score of 69 out of 100, placing it in the Developing tier among Healthcare brands, Technology brands. Among 2305 Healthcare brands analyzed, Cleerly ranks in the 56th percentile (category average 68, leader 95). The score combines seven dimensions - name quality, digital presence, visual identity, messaging clarity, trust foundation, AI discoverability, and brand authority - into a single objective benchmark. Dimension scores: Name Quality 98/100, Digital Presence 76/100, Visual Identity 80/100, Messaging Clarity 95/100, Trust Foundation 69/100, AI Discoverability 65/100, Brand Authority 24/100.
Cleerly is an American digital healthcare company headquartered in New York City. It offers an AI-enabled coronary computed tomography angiography (CCTA) solution designed to identify, characterize, and quantify plaque buildup in the heart. The platform provides a non-invasive whole heart assessment to determine a patient's risk of heart attack. Cleerly positions its technology as delivering higher diagnostic accuracy than traditional methods such as FFRCT and stress testing, targeting payors, healthcare providers, and patients.
| Brand Name | Cleerly |
|---|---|
| Domain | cleerlyhealth.com |
| Industry | Healthcare, Technology |
| Headquarters | New York City |
| Main Competitors | HeartFlow, Siemens Healthineers, Philips Healthcare, GE HealthCare, Arterys |
Moz Domain Authority 37/100 vs category average 29 / leader 95 - a strong backlink profile, so AI systems frequently encounter mentions of the brand.
Ranked #1,027,402 on the Tranco list of most-visited sites - modest traffic makes the brand easy for AI models to overlook.
No Wikipedia presence was found - a major gap, since Wikipedia is among the most heavily weighted sources in AI training data.
The homepage meta description reads "Cleerly determines your risk of heart attack by performing a non-invasive whole heart assessment to identify, characterize, and quantify plaque buildup." (Meta description: 21 words (ideal length). OG description present and descriptive) - this is the summary AI engines are most likely to quote.
Structured data on the homepage: og:title, og:description, Twitter cards, canonical. Adding Organization and FAQ schema would further help AI crawlers parse the brand's identity.
AI-crawler access: robots.txt present, no AI bot restrictions - robots.txt controls whether engines like GPTBot and ClaudeBot can read the site at all.
Social footprint: verified profiles on Instagram, LinkedIn, YouTube; no detected presence on Facebook, X (Twitter), GitHub - consistent profiles reinforce the brand's identity across the web.
0 Reddit mentions - community discussion signals real-world reputation to AI models.
Cleerly scores 31/100 for AI visibility - how well ChatGPT, Claude, Perplexity and Google AI Overviews can discover, identify and cite the brand.
Cleerly has a weak AI-visibility profile at 31/100 - a proxy for how readily ChatGPT, Perplexity and Google's AI Overviews can recognise and cite it. Its strongest area is recommendation likelihood (58/100) and its weakest is visibility (21/100). It benefits from a Wikidata knowledge-graph entry, a global traffic rank of #1,027,402 (Tranco) and open access for AI crawlers (GPTBot, ClaudeBot, etc.). The main gaps holding it back: no clear Wikipedia entity to anchor it in LLM training data, a low Moz Domain Authority of 37/100 and thin schema.org structured data.
Common questions people ask in Google, ChatGPT, Claude, Gemini, Perplexity, and other AI search engines.
Cleerly's main competitors include HeartFlow, Siemens Healthineers, Philips Healthcare, GE HealthCare, Arterys. These companies compete in the Healthcare space for similar customers, offering comparable products or services.
Sources: Cleerly official site
Cleerly offers an AI-enabled CCTA (coronary computed tomography angiography) solution. This product provides a non-invasive whole heart assessment that identifies, characterizes, and quantifies plaque buildup in coronary arteries. The solution delivers comprehensive, accurate, and trackable insights intended to support personalized heart attack prevention for payors, healthcare providers, and patients.
Sources: Cleerly official site
Popular alternatives to Cleerly include HeartFlow, Siemens Healthineers, Philips Healthcare, GE HealthCare, Arterys. Each is an established option in the Healthcare space; the best fit depends on your specific needs, budget, and required features.
Sources: Cleerly official site
Cleerly is an American digital healthcare company headquartered in New York City. It is an AI-powered cardiac imaging and analysis platform focused on heart attack prevention. The company operates in the healthcare and technology categories and offers a non-invasive whole heart assessment solution built around coronary computed tomography angiography (CCTA) technology enhanced with artificial intelligence.
Sources: Cleerly official site
Cleerly performs non-invasive whole heart assessments to identify, characterize, and quantify plaque buildup in the arteries. Using its AI-enabled CCTA solution, it determines a patient's risk of heart attack and provides comprehensive, accurate, and trackable insights that allow healthcare providers to personalize heart attack prevention strategies. The company positions its approach as more diagnostically accurate than traditional methods such as FFRCT and stress testing.
Sources: Cleerly official site
Cleerly has limited AI-search visibility, scoring 31/100 on Brand Analyzer's AI visibility composite (visibility 21, trust 22, recommendation 58). This estimates how likely AI engines like ChatGPT, Claude, Gemini and Perplexity are to know, trust, and recommend the brand.
Sources: Cleerly official site
Cleerly is headquartered in New York City. Cleerly operates in the Healthcare category.
Sources: Wikidata
Cleerly and HeartFlow are competitors in Healthcare. They target overlapping audiences; the right choice depends on your specific needs and priorities.
Sources: Cleerly official site
Cleerly is known for its AI-enabled CCTA (coronary computed tomography angiography) solution that provides non-invasive whole heart assessments. It is particularly recognized for its ability to identify, characterize, and quantify arterial plaque buildup to assess heart attack risk. The platform is noted for offering higher diagnostic accuracy than traditional cardiac testing methods like FFRCT and stress testing.
Sources: Cleerly official site
Cleerly scores 58/100 on Brand Analyzer's AI recommendation signal, indicating it is reasonably likely to be surfaced when AI assistants like ChatGPT suggest Healthcare options. Recommendation depends on crawlability, structured data, and category authority.
Sources: Cleerly official site
Cleerly's target audience includes payors (such as health insurance companies), healthcare providers (such as cardiologists and clinicians), and patients who are seeking advanced heart disease analysis and prevention. The platform is designed to serve both the clinical side of cardiac care and the individuals at risk of heart disease who are looking for more precise diagnostic and preventive tools.
Sources: Cleerly official site
Cleerly can improve AI discoverability by strengthening structured data (Organization and FAQ schema), maintaining an accurate Wikipedia/Wikidata entity, earning authoritative citations, and keeping content crawlable for AI bots. Brand Analyzer measures these as visibility, trust, and recommendation signals.
Sources: Cleerly official site
Ranked closest to Cleerly: Clairity (69/100), Sevita (69/100), Colib (69/100), Countable Labs (69/100).
A step up - brands to learn from: Zipari by mPulse (71/100), Zaina AI (71/100).
Category leader: Dassault Systèmes (95/100).